ESR1 and breast carcinoma: It has demonstrated efficacy in reducing the growth of diverse cancers, including ER-dependent and -independent breast cancer cell lines, PC-3 prostate cancer cells, SNU-761 HCC cells, and lung cancer in Lewis tumor-bearing mice [394, 395].